Approval · Notice of Compliance 5806 · 2004
DESYREL: Notice of Compliance 5806
Issued November 8, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5806
- Date
- November 8, 2004
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antidepressant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DESYREL | 00579351 | Cancelled Post Market |
| DESYREL | 00579378 | Cancelled Post Market |
| DESYREL DIVIDOSE | 00702277 | Cancelled Post Market |
Medicinal ingredients
- TRAZODONE HCL 50 MG per TAB
- TRAZODONE HCL 100 MG per TAB
- TRAZODONE HCL 150 MG per TAB